COSCIENS

Serial Number 98915645
653

Registration Progress

Application Filed
Dec 20, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

COSCIENS

Basic Information

Serial Number
98915645
Filing Date
December 20, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
653
Status Date
Oct 19, 2025
Application
Pending
Classes
001 003 005 030
+1 more

Rights Holder

COSCIENS Biopharma Inc.

03
Address
222 Bay Street, Suite 3000
Toronto, Ontario M5K1E7
CA

Ownership History

COSCIENS Biopharma Inc.

Original Applicant
03
Toronto, Ontario CA

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

16 events
Date Code Type Description Documents
Oct 19, 2025 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Oct 19, 2025 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Oct 19, 2025 CNSL R SUSPENSION LETTER WRITTEN Loading...
Sep 10, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 9, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 9, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 8, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 8, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Sep 8, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 8, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 9, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 9, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 9, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 7, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 28, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 20, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Avenanthramides and oat beta glucan for use as ingredients in cosmetics; active natural chemical ingredients in the nature of avenanthramides and oat beta glucan for use in the manufacture of nutritional supplements, cosmeceuticals, nutraceuticals, and pharmaceuticals
Class 003
Non-medicated toiletry preparations; personal care products, namely, body lotion, shower gel, body polish, body and foot scrub and non-medicated skin creams; animal and pet care products, namely, non-medicated grooming preparations in the nature of shampoos for animals, moisturizers for animals, and conditioners for animals, all containing humectants; oat based cosmetic products for animals, namely, non-medicated grooming preparations in the nature of animal skin creams and balms; cosmetics; cosmetics, namely, shampoo, anti-irritant creams, moisturizing creams, skin creams, skin balms, oat based cosmetic products, namely, skin moisturizing products in the form of creams, gels and lotions; sunblock and sunscreen lotions, eye shadow and blush powders, lip sticks and balms
Class 005
Nutritional supplements, medicated cosmeceuticals, namely, cosmetics for the treatment of skin conditions; nutraceuticals for use as dietary supplements; pharmaceuticals for reducing cholesterol, blood glucose and for the treatment of inflammatory bowel syndrome, atherosclerosis, hypoparathyroidism, autoimmune diseases, and inflammation; medical preparations, namely, orally administered macimorelin for diagnosis of growth hormone deficiency in children and adults; dietetic food and beverages adapted for medical or veterinary use; dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; avenanthramides for supplement purposes; avenanthramides for pharmaceutical purposes; nutraceuticals for use as dietary supplements containing avenanthramides;,medicated cosmeceuticals, namely, medicated skincare preparations containing avenanthramides; oat beta glucan for supplement purposes; oat beta glucan for pharmaceutical purposes; nutraceuticals for use as dietary supplements containing oat beta glucan; medicated cosmeceuticals, namely, medicated skincare preparations containing oat beta glucan; veterinary medicine products, namely, natural, non-antibiotic, anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, for dermatological use, medicated shampoo; feed additives for use as nutritional supplements; nutritional supplements, namely, oat based supplements;; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceuticals preparation for immunology and inflammation based diseases; pharmaceutical preparations used for the treatment of urological diseases; pharmaceutical preparations used for the treatment of hormonal disorders; synthetic peptides-containing pharmaceutical preparations used for hormonal treatments; pharmaceutical preparations used for the treatment of endocrine diseases; pharmaceutical preparations used for the treatment of haematological diseases; pharmaceutical preparations used for the treatment of age-related diseases; pharmaceutical preparations used for the treatment of ophthalmological disorders; pharmaceutical preparations used for the treatment of reproductive system disorders; pharmaceutical preparations used for the treatment of endometriosis; pharmaceutical preparations used for the treatment of uterine myoma; pharmaceutical preparations used for the treatment of benign prostatic hyperplasia; pharmaceutical preparations used for the treatment of tropical diseases; pharmaceutical preparations used for the treatment of infectious disease; pharmaceutical preparations used for the treatment of leishmaniasis; pharmaceutical preparations used for the treatment of obesity; pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes; pharmaceutical preparations based on LHRH antagonists platform for the treatment of hormonal disorders; pharmaceutical preparations used to stimulate growth hormone secretagogue for the diagnosis of growth hormone deficiency; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases; diagnostic agents, preparations and substances for medical purposes; pharmaceutical products, comprising human growth hormone secretagogues, ghrelin receptor agonists, ghrelin receptor antagonists, ghrelin mimetics, human growth hormone analogues, human growth hormone fusion proteins, human growth hormone releasing hormone analogues, auto immune modulating proteins, therapeutic antibodies, small molecule kinase inhibitors, phospholipids for the treatment of neurological disorders; pharmaceutical preparations for the treatment of nasopharyngeal disorders; antibiotics; antibacterial pharmaceuticals, antibacterial handwash, antibacterial spray, antibacterial cleaners, antibacterial soap, antibacterial detergents, antibacterial hand lotions, fungicidal preparations; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of rheumatoid diseases; pharmaceutical preparations for contraceptives and women's health; analgesic preparations, comprising small molecule kinase inhibitors, phospholipids, and therapeutic antibodies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for palliative treatments; pharmaceutical preparations for the treatment of addictions; pharmaceutical formulations for the treatment of paediatric indications; medical preparations, namely, medicinal oils, other than essential oils; medicated toiletry preparations
Class 030
Bread; flour; preparations made from cereals, namely, cereals crackers, dried cereal flakes, grain-based chips, grain-based snack foods, granola-based cereals, oat bran cereals, ready-to-eat cereals, breakfast cereals, cereal bars, cereal based energy bars, cereal based snack food, cereal flour; snack foods based on yeast extracts; yeast based snack foods; cereal based snack foods containing yeast beta glucan; yeast beta glucan for supplement purposes; dietary fiber to aid digestion oat based food products, namely, oat bran, oat flour, oat starch, oat beta glucan, and oat noodles
Class 032
Non-alcoholic beverages, namely isotonic non-alcoholic drinks, sports drinks, energy drinks, protein-enriched sports beverages; preparations for making non-alcoholic beverage, namely, concentrates, syrups or powders used in the preparation of isotonic sports drinks, energy drinks and sports beverages, and mixes for making sports drinks; beverages, namely, non alcoholic fibre health beverages for human and animal use

Classification

International Classes
001 003 005 030 032